This episode of Lung Cancer Considered is part of our series on FDA approvals of new lung cancer therapies. Today, host Dr. Stephen Liu discusses the EMPOWER-Lung 3 regimen of the PD-1 inhibitor cemiplimab with first-line platinum doublet chemotherapy for advanced NSCLC. This regimen was approved by the FDA on November 8, 2022. His guests are Dr. Jordi Remon, a thoracic medical oncologist who had previously practiced at Hospital de Mataro in Barcelona. He is now part of the esteemed thoracic uni...
Nov 29, 2022•41 min
Dr. Narjust Florez discusses the POSEIDON trial with guest Dr. Tejas Patil, assistant professor at Thoracic Oncology Research Initiative, University of Colorado Cancer Center. This Phase III study led to the recent FDA approval of Tremelimumab in combination with Durvalumab and chemotherapy as first line treatment in patients with metastatic non small-cell lung cancer (NSCLC).
Nov 28, 2022•33 min
In this episode of Lung Cancer Considered, host Dr. Stephen Liu, Director of Thoracic Oncology at Georgetown University, leads a discussion about the management of stage III NSCLC. Joining him are pulmonologist Dr. Martin Reck, Head of the Department of Thoracic Oncology and the Head of the Clinical Trials Department at the Lung Clinic Grosshansdorf and thoracic surgeon Dr. Paula Antonia Ugalde Figueroa, an Associate Surgeon in the Division of Thoracic Surgery at Brigham and Women’s Hospital in ...
Nov 15, 2022•54 min
There has been a steady stream of research presented that ties air pollution to an increased risk for lung cancer. To discuss this trend, Lung Cancer Considered host Dr. Narjust Florez interviews Dr. Roselle De Guzman, who is a medical oncologist and professor at the Manila Central University in the Philippines and the Chair of ASCO Asia Pacific Regional Council. Joining her is Dr. Christine D. Berg, former Chief, Early Detection Research Group, Division of Cancer Prevention, at the National Can...
Nov 15, 2022•41 min
At the time it was published in the New England Journal of Medicine in 2002, ECOG 1594 was the first study to compare whether any of the three chemotherapy regimens used at the time was superior to cisplatin and paclitaxel in patients with advanced non–small-cell lung cancer. In this episode of Lung Cancer Considered, hosts Dr. Stephen Liu and Dr. Narjust Florez interview the ECOG 1594 clinical trial investigators (Dr. Frances Shepherd, Dr. Alan Sandler, Dr. Chandra Belani, Dr. Corey Langer and ...
Nov 08, 2022•37 min
Lung cancer research is often centered at large, urban academic medical centers. But what research and treatment options are available for those patients with lung cancer who live in rural areas? In this episode of Lung Cancer Considered, host Dr. Narjust Florez discusses the state of rural lung cancer care and research with Dr. Debora Bruno, a thoracic medical oncologist at Case Western in Cleveland. Dr. Bruno worked in rural Nebraska for three years after the completion of her fellowship where...
Nov 01, 2022•43 min
In this special edition of Lung Cancer Considered, three esteemed oncologists and lung cancer experts explore the issues facing the medical profession in China. Host Dr. Chunxia Su, Professor of Oncology at Tongji University and Deputy Director of Medical Oncology at Shanghai Pulmonary Hospital, welcomes guests Prof. Shun Lu, Director of the Chinese Lung Cancer Association, Board Member of the Chinese Society of Clinical Oncology, and Director of the Shanghai Lung Cancer Center; and Prof. Caicun...
Oct 25, 2022•57 min
In keeping with its mission to cover lung cancer from a global perspective, this episode of Lung Cancer Considered focuses on lung cancer in Japan. Host Dr. Misako Nagasaka, a Thoracic Medical Oncologist from the University of California Irvine leads a Japanese-language discussion about lung cancer in Japan with respected oncologists Dr. Tetsuya Mitsudomi and Dr. Takashi Seto. Dr. Seto is a Thoracic Medical Oncologist from the National Kyushu Cancer Center in Fukuoka, Japan and Dr. Tetsuya Mitsu...
Oct 23, 2022•52 min
Over the past few years, the use of liquid biopsy has improved the ability to detect biomarkers for non-small cell lung cancer. In this episode of Lung Cancer Considered, host Dr. Stephen Liu leads a discussion on the current state of liquid biopsies with Dr. David Gandara, Professor of Medicine and Director of Thoracic Oncology at the University of California, Davis; Dr. Charu Aggarwal, the Leslye M. Heisler Associate Professor for Lung Cancer Excellence at the University of Pennsylvania; and D...
Oct 18, 2022•44 min
In this episode of Lung Cancer Considered, host Dr. Narjust Florez talks about the critical role interventional pulmonologists play on the cancer care team. Joining the discussion are Dr. Daniel Sterman, the Thomas and Suzanne Murphy Professor of Pulmonary and Critical Care Medicine at the New York University Grossman School of Medicine and Dr. Rebecca Krochmal, Assistant Professor of Medicine in the Division of Pulmonary, Critical Care and Sleep Medicine at the Georgetown University School of M...
Oct 11, 2022•37 min
Did you miss ESMO this year? Listen to Lung Cancer Considered host and thoracic oncologist Dr. Narjust Florez discuss the key highlights involving science and notable abstracts at the meeting with Dr. Joshua Reuss, Thoracic Medical Oncologist and Assistant Professor of Medicine at Georgetown and Dr. Giannis Mountzios, Director of the Oncology Department and Clinical Trials Unit at Henry Dunant Hospital Center in Athens, Greece.
Oct 07, 2022•46 min
The role of the pathologist in lung cancer treatment has dramatically evolved as our understanding of lung cancer biology has advanced. Lung Cancer Considered host Dr. Stephen Liu discusses that evolution with renowned lung cancer pathologists Dr. Dara Aisner from the University of Colorado and Dr. Ignacio Wistuba from MD Anderson Cancer Center. Dr. Wistuba is a Professor in the Department of Thoracic and Head and Neck Medical Oncology at the University of Texas MD Anderson Cancer Center in Hous...
Oct 04, 2022•46 min
Lung Cancer Considered Host Dr. Stephen Liu leads a recap of the recently completed IASLC 2022 North America Conference on Lung Cancer featuring guests Dr. Jessica Donington, Professor and Chief Thoracic Surgery University of Chicago; Dr.Jyoti Patel, Thoracic Medical Oncology, Robert H Lurie Comprehensive Cancer Center, Northwestern University and Dr. Shruti Patel, Oncology Fellow at Stanford School of Medicine.
Sep 29, 2022•30 min
Career transitions are normal in academic oncology, oncology practice, and industry and today's oncologists go through a number of 'job' interviews during their post-graduate life and early career. In this episode of Lung Cancer Considered, host Dr. Narjust Florez discusses how to find or transition to that new job in thoracic oncology. Joining the discussion are three lung cancer researchers: Dr. Mark Awad, clinical director of the Thoracic Oncology Group at Dana Farber Cancer Institute, assist...
Sep 20, 2022•46 min
Treatment for malignant pleural mesothelioma has undergone dramatic shifts in the past few years. To discuss these changes and the research behind them, Lung Cancer Considered Host Dr. Stephen Liu welcomes Dr. Sanjay Popat and Dr. Melina Marmarelis. Dr. Popat is a Consultant Thoracic Medical Oncologist at The Royal Marsden and Professor of Thoracic Oncology at the Institute of Cancer Research, in London, England, and Chair of the British Thoracic Oncology Group. He is also on the Board of Direct...
Sep 06, 2022•31 min
In this episode of Lung Cancer Considered, host Dr. Stephen Liu leads a discussion on the management of metastatic, PDL1 negative NSCLC. He is joined by Dr. Hossein Borghaei and Dr. Reyes Bernabe Caro. Dr. Borghaei is a professor and Chief of Thoracic Oncology at Fox Chase Cancer Center in Philadelphia. He was the lead author for CheckMate 057, was involved in many of the landmark immunotherapy trials, and is the national PI for the ongoing INSIGNA trial. Dr. Reyes Bernabe Caro is the Section Ch...
Aug 16, 2022•37 min
On the heels of accelerated approval by the US FDA, Dr. Stephen Liu discusses trastuzumab-deruxtecan (T-DXd) with medical oncologists and clinical investigators, Dr. Lyudmila Bazhenova, from the University of California, San Diego, and Dr. Julian Mazieres, from Toulouse University Hospital. T-DXd is an antibody-drug conjugate now approved for the treatment of HER2-mutant NSCLC, and in this episode, its design, efficacy, and safety are reviewed.
Aug 12, 2022•38 min
It’s a wrap! Catch up on key highlights of the IASLC 2022 World Conference on Lung Cancer with Dr. Narjust Florez and Dr. Stephen Liu as they discuss the science, social engagement and notable abstracts with Dr. Ben Levy.
Aug 11, 2022•23 min
We’ve approached a remarkable close to the last day of the IASLC 2022 World Conference on Lung Cancer in Vienna, Austria. Lung Cancer Considered hosts Dr. Stephen Liu and Dr. Narjust Florez interview Dr. Belinda King Kallimanis, Dr. Charles Rudin and Dr. Solange Peters about patient-centric clinical trial consent forms, an update on the Keynote 604 trial, the importance of women’s sexual health and new data on a combination of therapies for patients with KRAS mutations.
Aug 09, 2022•27 min
Destacados Diarios WCLC 2022 - 8 de Agosto Es el tercer día de la Conferencia Mundial IASLC 2022 sobre Cáncer de Pulmón! La Dra. Narjust Florez recibe a dos investigadores fundamentales: El Dr. Mariano Provencio y La Dra. Enriqueta Felip, para discutir sus estudios mejor calificados.
Aug 09, 2022•12 min
It’s Day 3 at the IASLC 2022 World Conference on Lung Cancer! Dr. Narjust Florez hosts pivotal researchers Dr. Enriqueta Felip, Dr. Mariano Provencio, and Dr. Rachael Murray to discuss their top-rated studies. IASLC President Dr. Heather Wakelee also joins in to give insight on how the committee selected these high-ranked abstracts for this year’s Presidential Symposium.
Aug 08, 2022•41 min
In this special edition of Lung Cancer Considered recorded at the IASLC 2022 World Conference on Lung Cancer, hosts Dr. Narjust Florez and Dr. Stephen Liu interview researchers Dr. Chi-Fu Jeffrey Yang, Dr. Jarushka Naidoo and Mr. Koen de Nijs, PhD student, to discuss their recent findings from the significant studies presented today.
Aug 07, 2022•24 min
Today's podcast originates from the IASLC World Conference on Lung Cancer in Vienna. Hosts Dr. Stephen Liu and Dr. Narjust Florez interview IASLC WCLC 2022 Honorary Chair Dr. Robert Pirker and Chair Dr. Silvia Novello at the meeting. Dr. Pirker and Dr. Novello provide an overview of the meeting and give podcast listeners a glimpse of what to expect at the IASLC WCLC 2022.
Aug 06, 2022•17 min
On this episode of Lung Cancer Considered, three past IASLC Fellowship Grants winners share their own stories of how these grants helped propel their careers. Hosted by Dr. Narjust Florez, guests include: Dr. Grace Dy is an associate professor of medicine at Department of Medicine at Jacobs School of Medicine & Biomedical Sciences at the University of Buffalo and a medical thoracic oncologist at Roswell Park Cancer Center. Dr. Dy received an IASLC fellowship grant in 2007. Fred R. Hirsch, MD...
Aug 02, 2022•40 min
The IASLC World Conference on Lung Cancer will be held in person this year in Vienna. Lung Cancer Considered Hosts Dr. Narjust Florez and Dr. Stephen Liu preview the meeting highlights and provide advice on how to plan your own experience and what scientific sessions might be the most interesting. This podcast episode is a must listen for all in person attendees and those participating virtually from their home or office.
Jul 26, 2022•24 min
In this episode of Lung Cancer Considered, host Dr. Narjust Florez leads a discussion of the unique challenges women in oncology face as they navigate career pathways. She is joined by Dr. Prunella Blinman, a medical oncologist at Concord Repatriation General Hospital in Sydney, Australia and clinical associate professor at the University of Sydney. Also joining the discussion is Dr. Clarissa Mathias, medical oncologist and director of NOB/Oncoclinicas in Brazil. She is a member of the ASCO Inte...
Jul 19, 2022•38 min
In keeping with IASLC's international focus, this episode of Lung Cancer Considered focuses on the state of lung cancer in Germany. This episode is hosted by Dr. Alessandra Curioni, Thoracic Medical Oncologist at the University of Zurich and her guests are two of the most prominent lung cancer experts in Germany -- Dr. Martin Reck, Head of the Department of Thoracic Oncology and the Head of the Clinical Trials Department at the Lung Clinic Grosshansdorf and Dr. Juergen Wolf, Medical Director for...
Jul 12, 2022•37 min
This episode of Lung Cancer Considered examines the state of lung cancer care and research in South Africa. Joining host Dr. Stephen Liu is Dr. Ronwyn van Eeden, a medical oncologist practicing in Rosebank, South Africa. Dr. van Eeden has just started her own oncology unit and is also an honorary consultant in medical oncology at the Chris Hani Baragwanath Academic Hospital.
Jul 05, 2022•41 min
Dr. Marina Garassino and Dr. Suresh Ramalingam join Lung Cancer Considered host Dr. Narjust Florez to share experiences as international medical graduates. Dr. Garassino is an internationally recognized expert in the treatment of thoracic malignancies from the Medical School of Università degli Studi of Milan, Italy, She recently joined the University of Chicago as the chief of the Thoracic Oncology Group. Dr. Suresh Ramalingam is the Executive Director, Winship Cancer Institute of Emory Univers...
Jun 21, 2022•37 min
In this episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu discuss the recently completed ASCO meeting with colleagues Dr. Catherine Shu and Dr. Jack West. Dr. Shu is a board-certified medical oncologist specializing in the treatment of thoracic cancers, especially lung cancer, at Columbia University's Herbert Irving Comprehensive Cancer Center. Dr. West is a medical oncologist at City of Hope Cancer Center and is the founder of the Global Resource for Advancing Canc...
Jun 09, 2022•46 min
